Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Bio-Path Holdings Company Profile (NASDAQ:BPTH)

Consensus Ratings for Bio-Path Holdings (NASDAQ:BPTH) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $5.00 (155.10% upside)

Analysts' Ratings History for Bio-Path Holdings (NASDAQ:BPTH)
Show:
DateFirmActionRatingPrice TargetDetailsShare
6/2/2014Maxim GroupInitiated CoverageBuy$5.00ViewTweet This Rating  Share This Rating on StockTwits
5/9/2014Maxim GroupInitiated CoverageBuy$5.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/2/2012 forward)
Discuss Bio-Path Holdings